Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.38% | -23.38% | 9.89% | 45.58% | 45.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -99.19% | -- | -- |
| Total Operating Expenses | -5.03% | -5.03% | -77.13% | -6.17% | -6.17% |
| Operating Income | 5.03% | 5.03% | -548.66% | 6.17% | 6.17% |
| Income Before Tax | 33.38% | 33.38% | -225.20% | -7.04% | -7.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.38% | 33.38% | -225.20% | -7.04% | -7.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.38% | 33.38% | -225.20% | -7.04% | -7.04% |
| EBIT | 5.03% | 5.03% | -548.66% | 6.17% | 6.17% |
| EBITDA | 10.66% | 10.66% | -481.80% | 3.78% | 3.78% |
| EPS Basic | 33.48% | 33.48% | -225.00% | -6.49% | -6.49% |
| Normalized Basic EPS | 26.61% | 26.61% | -224.94% | 3.40% | 3.40% |
| EPS Diluted | 33.48% | 33.48% | -225.00% | -6.49% | -6.49% |
| Normalized Diluted EPS | 26.61% | 26.61% | -224.94% | 3.40% | 3.40% |
| Average Basic Shares Outstanding | 0.19% | 0.19% | 0.09% | 0.54% | 0.54% |
| Average Diluted Shares Outstanding | 0.19% | 0.19% | 0.09% | 0.54% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |